Log In
Print
BCIQ
Print
Print this Print this
 

Vyndaqel, tafamidis meglumine (Fx-1006A)

  Manage Alerts
Collapse Summary General Information
Company Pfizer Inc.
DescriptionSmall molecule that stabilizes transthyretin (TTR) protein and prevents misfolding
Molecular Target Transthyretin (TTR)
Mechanism of ActionTransthyretin (TTR) dissociation inhibitor
Latest Stage of DevelopmentApproved
IndicationAmyloidosis
Partner

 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today